GSK-239512
CAS: 720691-69-0
Ref. 3D-VDB69169
| 1g | Nachfragen | ||
| 50mg | Nachfragen | ||
| 100mg | Nachfragen | ||
| 250mg | Nachfragen | ||
| 500mg | Nachfragen |
Produktinformation
GSK-239512 is a clinical candidate for the treatment of chronic inflammatory diseases. It is a potent antagonist of the IL-6 receptor and has been shown to have immunomodulatory effects in preclinical models. GSK-239512 has been studied in an oral chronic toxicity study in rats at doses of up to 600 mg/kg/day for 18 months, with no evidence of any toxic effect. The drug was not found to cross the blood-brain barrier or cause any effect on the central nervous system. In molecular modeling studies, GSK-239512 was found to bind to IL-6 receptors and block signaling pathways associated with inflammation, including those that lead to neutrophil recruitment, endothelial activation and platelet aggregation.
GSK-239512 has been shown to be safe at doses up to 600 mg/kg/day in nonclinical studies and was well tolerated by animals at doses up to 600 mg/kg/day in a long term
Chemische Eigenschaften
Technische Anfrage zu: 3D-VDB69169 GSK-239512
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.
